Cite
HARVARD Citation
de Koning, H. et al. (2013). Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome. Annals of the rheumatic diseases. 72 (10), pp. 1634-1638. [Online].